Total Payments
$4,648
2024 Payments
$347.95
Companies
22
Transactions
174
Medicare Patients
4,303
Medicare Billing
$323,926
Payment Breakdown by Category
Food & Beverage$4,575 (98.4%)
Education$72.73 (1.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,575 | 173 | 98.4% |
| Education | $72.73 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,258 | 66 | $0 (2024) |
| Lilly USA, LLC | $396.37 | 17 | $0 (2024) |
| Celgene Corporation | $336.03 | 4 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $305.77 | 14 | $0 (2022) |
| PFIZER INC. | $205.39 | 11 | $0 (2022) |
| UCB, Inc. | $200.81 | 9 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $188.26 | 13 | $0 (2024) |
| GENZYME CORPORATION | $166.12 | 8 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $145.46 | 8 | $0 (2024) |
| Amgen Inc. | $108.33 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $347.95 | 15 | Amgen Inc. ($93.30) |
| 2023 | $18.45 | 1 | GENZYME CORPORATION ($18.45) |
| 2022 | $871.02 | 51 | ABBVIE INC. ($301.36) |
| 2021 | $984.41 | 55 | AbbVie Inc. ($239.70) |
| 2020 | $327.15 | 17 | AbbVie Inc. ($93.44) |
| 2019 | $748.83 | 14 | AbbVie, Inc. ($629.43) |
| 2018 | $1,196 | 18 | AbbVie, Inc. ($786.19) |
| 2017 | $153.78 | 3 | AbbVie, Inc. ($131.16) |
All Payment Transactions
174 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Immunology | ||||||
| 08/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $31.68 | General |
| Category: Inflammation | ||||||
| 08/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Immunology | ||||||
| 08/15/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Dermatology | ||||||
| 08/01/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Dermatology | ||||||
| 07/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Dermatology | ||||||
| 06/17/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $31.52 | General |
| Category: Immunology | ||||||
| 05/30/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $31.90 | General |
| Category: Inflammation | ||||||
| 04/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: Inflammation | ||||||
| 04/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: Immunology | ||||||
| 03/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: IMMUNOLOGY | ||||||
| 02/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.12 | General |
| Category: Immunology | ||||||
| 02/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Immunology | ||||||
| 09/30/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $34.58 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2022 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Immunology | ||||||
| 08/17/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.96 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: IMMUNOLOGY | ||||||
| 07/28/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 532 | 691 | $97,588 | $33,071 |
| 2022 | 9 | 365 | 552 | $112,260 | $19,971 |
| 2021 | 18 | 2,866 | 4,710 | $1.0M | $238,336 |
| 2020 | 10 | 540 | 717 | $135,377 | $32,548 |
Total Patients
4,303
Total Services
6,670
Medicare Billing
$323,926
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 124 | 130 | $22,360 | $8,430 | 37.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 95 | 97 | $18,624 | $6,616 | 35.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 57 | 57 | $12,084 | $4,533 | 37.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 42 | 46 | $9,798 | $3,795 | 38.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 90 | 95 | $12,255 | $3,219 | 26.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 13 | 16 | $5,408 | $1,813 | 33.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 29 | 47 | $4,794 | $1,773 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 12 | $2,916 | $1,076 | 36.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 23 | $2,461 | $975.89 | 39.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 49 | 168 | $6,888 | $840.36 | 12.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 61 | 61 | $21,104 | $4,400 | 20.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 48 | 56 | $20,340 | $3,733 | 18.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 61 | 71 | $23,121 | $3,486 | 15.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 65 | $18,070 | $3,366 | 18.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 60 | 73 | $15,446 | $2,373 | 15.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 17 | 24 | $4,161 | $872.44 | 21.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 38 | 171 | $3,760 | $826.66 | 22.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 18 | $3,078 | $587.79 | 19.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 13 | 13 | $3,180 | $325.59 | 10.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 705 | 910 | $240,288 | $61,695 | 25.7% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 367 | 489 | $177,610 | $43,852 | 24.7% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 395 | 471 | $153,381 | $32,549 | 21.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 190 | 216 | $80,172 | $20,285 | 25.3% |
| 17000 | Destruction of skin growth | Office | 2021 | 401 | 546 | $115,528 | $19,909 | 17.2% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 136 | 269 | $46,637 | $12,259 | 26.3% |
About Dr. Jessika Davis, M.D
Dr. Jessika Davis, M.D is a Dermatology healthcare provider based in Asheville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2016. The National Provider Identifier (NPI) number assigned to this provider is 1316391410.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jessika Davis, M.D has received a total of $4,648 in payments from pharmaceutical and medical device companies, with $347.95 received in 2024. These payments were reported across 174 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,575).
As a Medicare-enrolled provider, Davis has provided services to 4,303 Medicare beneficiaries, totaling 6,670 services with total Medicare billing of $323,926. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology, Dermatology
- Location Asheville, NC
- Active Since 04/15/2016
- Last Updated 02/22/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1316391410
Products in Payments
- Humira (Biological) $1,226
- Otezla (Drug) $412.79
- TALTZ (Drug) $396.37
- SKYRIZI (Biological) $329.71
- DUPIXENT (Biological) $256.75
- EUCRISA (Drug) $205.39
- HUMIRA (Biological) $203.25
- RINVOQ (Biological) $178.41
- LIBTAYO (Biological) $145.94
- Cimzia (Drug) $139.42
- Ilumya (Biological) $139.12
- COSENTYX (Biological) $92.16
- Bimzelx (Biological) $61.39
- Skyrizi (Biological) $46.62
- TREMFYA (Drug) $36.45
- CLODERM (Drug) $33.41
- ORACEA (Drug) $30.71
- AKLIEF (Drug) $29.82
- OPZELURA (Drug) $28.20
- DUOBRII (Drug) $25.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Asheville
Dr. Michael Rains, M.d, M.D
Dermatology — Payments: $150,060
Dermatology $150,060
Dr. Justin Sigmon, Md, MD
Dermatology — Payments: $4,646
Dermatology $4,646
Hugh Dorris, Md, MD
Dermatology — Payments: $4,402
Dermatology $4,402
Dr. Marie Ventre, Md, MD
Dermatology — Payments: $3,740
Dermatology $3,740
Alison Lyke, Md, MD
Dermatology — Payments: $2,171
Dermatology $2,171
Dr. Lowell Michael, M.d., Ph.d, M.D., PH.D
Dermatology — Payments: $1,819
Dermatology $1,819